Page 1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement , makes no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement . CSPC CSPC PHARMACEUTICAL GROUP LIMITED 石 藥 集團 有限公司 ( Incorporated in Hong Kong with limited liability ) ( Stock code : 1093 ) 2021 INTERIM RESULTS ANNOUNCEMENT FINANCIAL HIGHLIGHTS For the six months ended 30 June 2021 RMB'000 ( Unaudited ) 2020 RMB'000 ( Unaudited ) Change Revenue by business units : Finished drugs 11,233,382 10,231,025 + 9.8 % Bulk products Vitamin C 1,080,770 1,004,964 + 7.5 % -Antibiotics and others 835,857 638,822 + 30.8 % Functional food and others 672,266 714,786 -5.9 % Total revenue 13,822,275 12,589,597 + 9.8 % Profit attributable to shareholders 3,062,569 2,313,996 + 32.3 % RMB cents RMB cents ( Restated ) Earnings per share - Basic ― Diluted 25.62 25.62 19.36 19.35 32.3 % 32.4 % The Board has declared an interim dividend of HK8 cents per share for 2021 . -1-